Posts by: Sreetama Dutt

Sreetama Dutt

Sreetama Dutt is a news curator and columnist at Lung Disease News. She studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK.

September 24, 2015November 9, 2015

Pulmatrix To Report Phase IB Data For PUR0200 COPD Therapy At European Respiratory Society Congress

COPD, News

Pulmatrix, a biotechnology company developing inhalable formulations using its patented iSPERSE technology for patients affected by severe pulmonary abnormalities, recently announced that the company will be reporting key data from a phase IB clinical ... Read more

September 24, 2015November 5, 2015

Clinical Trial Data On PH Therapy Selexipag (Uptravi) & Macitentan (Opsumit) To Be Presented At European Respiratory Society Congress

News, Pulmonary Hypertension

Actelion BioPharmaceuticals recently announced that the company will be releasing important data from its Phase III GRIPHON study testing the efficacy and tolerability of their pipeline drug selexipag (Uptravi®) for the treatment ... Read more

September 23, 2015November 6, 2015

Aradigm Completes Patient Enrollment For Phase III Trial To Test Novel non-Cystic Fibrosis Bronchiectasis Therapy

Bronchiectasis, News

Aradigm, an emerging pharmaceutical company dedicated to the development and commercialization of drugs to treat a wide range of respiratory ailments, recently announced the completion of patient enrollment for ORBIT (Once-daily ... Read more

September 22, 2015September 22, 2015

EORTC Trial To Evaluate Efficacy Of Functional Imaging For Determining Treatment Options in NSCLC Patients

Lung Cancer, News

Non Small Cell Lung Cancer (NSCLC) is the leading cause of tumor-related deaths in the world, with over one million patients dying from the disease annually. Deciding on a line of ... Read more

September 22, 2015November 5, 2015

Mosaic Pattern of Lung Attenuation on Chest CT Scans Detected in Some Pulmonary Hypertension Patients

News, Pulmonary Hypertension

A new study identified a mosaic pattern of lung attenuation on chest CT scans detected in some Pulmonary Hypertension patients, particularly those patients with CTEPH. The study, entitled “Mosaic Pattern of ... Read more

September 17, 2015November 5, 2015

ProQR Begins Enrollment in Clinical Trial Testing New Cystic Fibrosis Therapy

Cystic Fibrosis, News

ProQR therapeutics recently announced that they have begun enrolling patients for their open-label, exploratory trial PQ-010-002, which will evaluate the effect of their novel investigational therapeutic formulation QR-010 in ∆F508 homozygous ... Read more

September 14, 2015November 6, 2015

Teva’s sNDA For Bronchospasm Therapy ProAir RespiClick Gets US FDA Approval For Review

Asthma, News

The US Food and Drug Administration (FDA) recently accepted review of the supplemental New Drug Application (sNDA) filed by Teva Pharmaceuticals‘ novel drug formulation Pro Air RespiClick. The therapy is ... Read more

September 11, 2015November 5, 2015

MediciNova’s Experimental IPF Therapy Gets Fast Tracked By US FDA

Idiopathic Pulmonary Fibrosis, News

The US FDA (Food and Drug administration) recently granted a Fast Track designation to MediciNova’s novel drug formulation MN-001 (tipelukast) aimed at treating patients with idiopathic pulmonary fibrosis (IPH). This ... Read more

September 11, 2015November 5, 2015

Novel C-Pulse Technology Could Help Treat Pulmonary Arterial Hypertension

News, Pulmonary Hypertension

Sunshine Heart, Inc., a company that develops medical devices to aid in cardiac muscle related complications, recently announced a new collaboration with Dr. Mark Slaughter and the University of Louisville to study ... Read more

May 12, 2015November 9, 2015

NLRX1 Identified As Crucial Checkpoint In COPD Lung Damage

COPD, News

Scientists from Brown and Yale University have uncovered a new mitochondrial pathway whose expression acts as a switch that triggers Chronic Obstructive Pulmonary Disease (COPD) in patients. COPD is the third largest ... Read more